Le Traitement Hormonal Du Cancer Du Sein En Phase Avancee. Méthodes détude : Comparaison de la Delta-1 -Testololactone avec le Propionate de Testostérone*

Abstract

The authors describe and comment the protocol of the European disseminated breast cancer Group. This protocol was followed to compare the efficacy of the treatment with testosterone propionate to the treatment with delta-i-tcsto- lolactone, a new compound devoid of virilizing properties, although of a formula similar to androgens. There were 9 regressions, according to the criteria, among 59 patients treated with delta-i-testololactone and 8 regressions among 49 patients treated with testosterone propionate.